Publication:
The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial

dc.contributor.authorBlanco-Rojo, Ruth
dc.contributor.authorAlcala-Diaz, Juan F.
dc.contributor.authorWopereis, Suzan
dc.contributor.authorPerez-Martinez, Pablo
dc.contributor.authorQuintana-Navarro, Gracia M.
dc.contributor.authorMarin, Carmen
dc.contributor.authorOrdovas, Jose M.
dc.contributor.authorvan Ommen, Ben
dc.contributor.authorPerez-Jimenez, Francisco
dc.contributor.authorDelgado-Lista, Javier
dc.contributor.authorLopez-Miranda, Jose
dc.contributor.authoraffiliation[Blanco-Rojo, Ruth] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Alcala-Diaz, Juan F.] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Perez-Martinez, Pablo] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Quintana-Navarro, Gracia M.] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Marin, Carmen] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Perez-Jimenez, Francisco] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Delgado-Lista, Javier] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Lopez-Miranda, Jose] Reina Sofia Univ Hosp, Lipids & Atherosclerosis Res Unit, Cordoba 14004, Spain
dc.contributor.authoraffiliation[Blanco-Rojo, Ruth] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Alcala-Diaz, Juan F.] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Perez-Martinez, Pablo] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Quintana-Navarro, Gracia M.] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Marin, Carmen] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Perez-Jimenez, Francisco] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Delgado-Lista, Javier] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Miranda, Jose] Maimonides Inst Biomed Res Cordoba IMIBIC, Nutrigen & Metab Syndrome, Cordoba, Spain
dc.contributor.authoraffiliation[Blanco-Rojo, Ruth] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Alcala-Diaz, Juan F.] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Perez-Martinez, Pablo] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Quintana-Navarro, Gracia M.] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Marin, Carmen] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Perez-Jimenez, Francisco] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Delgado-Lista, Javier] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Miranda, Jose] Univ Cordoba, Dept Med, Cordoba, Spain
dc.contributor.authoraffiliation[Blanco-Rojo, Ruth] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Alcala-Diaz, Juan F.] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Perez-Martinez, Pablo] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Quintana-Navarro, Gracia M.] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Marin, Carmen] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Perez-Jimenez, Francisco] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Delgado-Lista, Javier] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Lopez-Miranda, Jose] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain
dc.contributor.authoraffiliation[Wopereis, Suzan] TNO, NL-3700 AJ Zeist, Netherlands
dc.contributor.authoraffiliation[van Ommen, Ben] TNO, NL-3700 AJ Zeist, Netherlands
dc.contributor.authoraffiliation[Ordovas, Jose M.] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA
dc.contributor.authoraffiliation[Ordovas, Jose M.] IMDEA Food Inst, Madrid, Spain
dc.contributor.funderMinisterio de Economia y Competitividad
dc.contributor.funderMinisterio de Ciencia e Innovacion
dc.contributor.funderEuropean Commission (NUTRITECH European Integrated Project)
dc.contributor.funderISCIII
dc.contributor.funderInstituto de Salud Carlos III research contract (Programa Rio-Hortega)
dc.date.accessioned2023-02-12T02:20:18Z
dc.date.available2023-02-12T02:20:18Z
dc.date.issued2015-09-08
dc.description.abstractAims/hypothesis The aim of the study was to determine whether basal insulin resistance (IR) phenotype (muscle and/or liver) determines the effect of long-term consumption of a Mediterranean diet or a low-fat diet on tissue-specific IR and beta cell function.Methods The study was performed in 642 patients included in The effect of an olive oil rich Mediterranean diet on type 2 diabetes mellitus risk and incidence study (CORDIOPREVDIAB). A total of 327 patients were randomised to a Mediterranean diet (35% fat; 22% from monounsaturated fatty acids) and 315 to a low-fat diet (<28% fat). At baseline, the patients were classified into four phenotypes according to the type of IR: (1) no IR; (2) muscle IR; (3) liver IR; (4) muscle+liver IR. The hepatic insulin resistance index (HIRI), muscular insulin sensitivity index (MISI) and disposition index were analysed at baseline and after 2 years of follow-up. Results At baseline, 322 patients presented no IR, 106 presented muscle IR, 109 presented liver IR, and 105 presented muscle+liver IR. With both dietary interventions, HIRI decreased in all patients (p<0.001) and MISI increased in muscle IR and muscle+liver IR patients (p<0.01). Long-term intake of the Mediterranean diet increased the disposition index and insulinogenic index in the muscle IR patients (p=0.042 and p=0.044, respectively) and the disposition index in the muscle+liver IR patients (p=0.048), whereas the low-fat diet increased the disposition index in the liver IR patients (p=0.017). Conclusions/interpretation Although both diets improve insulin sensitivity, there are differences based on basal IR phenotypes. Moreover, according to insulinogenic and disposition index data, a low-fat diet might be more beneficial topatients with liver IR, whereas patients with muscle IR and muscle+liver IR might benefit more from a Mediterranean diet.
dc.description.versionSi
dc.identifier.citationBlanco-Rojo R, Alcala-Diaz JF, Wopereis S, Perez-Martinez P, Quintana-Navarro GM, Marin C, et al. The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial. Diabetologia. 2016 Jan;59(1):67-76
dc.identifier.doi10.1007/s00125-015-3776-4
dc.identifier.essn1432-0428
dc.identifier.issn0012-186X
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s00125-015-3776-4.pdf
dc.identifier.urihttp://hdl.handle.net/10668/18621
dc.identifier.wosID365804500009
dc.issue.number1
dc.journal.titleDiabetologia
dc.journal.titleabbreviationDiabetologia
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number67-76
dc.publisherSpringer
dc.relation.projectIDAGL2012/39615
dc.relation.projectIDPIE14/00005 and PI13/00023
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s00125-015-3776-4
dc.rights.accessRightsopen access
dc.subjectBeta cell function
dc.subjectDietary intervention
dc.subjectInsulin resistance
dc.subjectLow-fat diet
dc.subjectMediterranean diet
dc.subjectMediterranean diet
dc.subjectGlucose-tolerance
dc.subjectSkeletal-muscle
dc.subjectLife-style
dc.subjectPrevention
dc.subjectSensitivity
dc.subjectHealth
dc.subjectRisk
dc.subjectMetabolism
dc.subjectSecretion
dc.subject.decsAceite de oliva
dc.subject.decsDiabetes mellitus tipo 2
dc.subject.decsDieta mediterránea
dc.subject.decsDieta con restricción de grasas
dc.subject.decsEstudios de seguimiento
dc.subject.decsHígado
dc.subject.decsResistencia a la insulina
dc.subject.meshInsulin resistance
dc.subject.meshOlive oil
dc.subject.meshDiabetes mellitus, type 2
dc.subject.meshDiet, fat-restricted
dc.subject.meshDiet, mediterranean
dc.subject.meshFollow-up studies
dc.subject.meshLiver
dc.subject.meshFatty acids, monounsaturated
dc.subject.meshPhenotype
dc.subject.meshMuscles
dc.titleThe insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number59
dc.wostypeArticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format